4月30日富国精准医疗混合A净值增长2.06%，近3个月累计上涨28.98%

Group 1 - The core viewpoint of the news is the performance and holdings of the Fuqua Precision Medical Mixed A fund, which has shown significant growth in recent months and has a strong portfolio in the healthcare sector [1][3] - As of April 30, 2025, the latest net value of the Fuqua Precision Medical Mixed A fund is 2.8501 yuan, reflecting a growth of 2.06% [1] - The fund's one-month return is 11.21%, ranking 8 out of 2325 in its category, while its three-month return is 28.98%, ranking 10 out of 2318 [1] - Year-to-date, the fund has achieved a return of 27.90%, ranking 22 out of 2307 [1] Group 2 - The top ten stock holdings of the Fuqua Precision Medical Mixed A fund account for a total of 69.71%, with significant positions in companies such as Baillie Gifford (9.66%), Haisco (9.65%), and Kelun Pharmaceutical (9.10%) [1] - The fund was established on November 16, 2017, and as of March 31, 2025, it has a total scale of 3.746 billion yuan [1] - The fund manager, Zhao Wei, has extensive experience in the pharmaceutical and investment sectors, having held various positions in companies such as GlaxoSmithKline and China Merchants Fund Management [2]